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1. Introduction 
Worldwide research has shown that racial differences occur with regard to the histological 
subtypes, response to treatment and outcome of idiopathic nephrotic syndrome (INS) in 
children (Bhimma et al. 2006:1847; Bhimma, R. 2009:15; Ingulli &Tejani 2001:393). Several 
reasons have been suggested to explain these differences such as a higher prevalence of 
infections, lower socio-economic status and inequalities in access to health care resources, 
genetics, and environmental factors but none of these have been substantiated by data. 
Results from the International Study of Kidney Disease in Children (International Study of 
Kidney Disease in Children ISKDC 1978:159) showed that the majority of children with INS 
have minimal change nephrotic syndrome (MCNS) which responds to corticosteroid 
treatment and that a kidney biopsy is not indicated. Based on these findings empiric 
corticosteroid treatment was recommended, without performing a kidney biopsy. The study 
population consisted of predominantly white children from North America, Europe and 
Asia. These recommendations have been implemented worldwide as standard of care for 
the past 40 years despite the lack of prospective renal biopsy studies to substantiate this 
recommendation and which may not be applicable to other settings with a predominance of 
black patients. An increasing incidence of focal segmental glomerulosclerosis (FSGS) in 
children and adults with INS has been reported recently (Borges et al. 2007:1309; Filler et al. 
2003 :1107; Srivastava et al. 1991:13). Studies reporting the outcome of INS associated with 
FSGS are variable, which is not surprising, as differences in the population mix, aetiology, 
pathogenesis and duration of disease are often not taken into consideration. This begs the 
question whether the recommendation of the International Study of Kidney Disease in 
Children for the management of INS should still be adhered to. Or should it be revised 
taking into consideration different racial groups? On the other hand, in the light of the rising 
incidence of FSGS, it may be prudent to withdraw the recommendation. 
Paediatric nephrologists from developing countries, and specifically Africa, need to formulate 
guidelines specific to their patients with INS. To this end, relevant clinical characteristics such 
as the antenatal and family history, birth weight, feeding and nutrition, growth and onset of 
disease should be documented and analysed in their reports. Low birth weight (LBW) which 
has been shown to be associated with decreased glomerular endowment (Manalich et al. 
2007:770, Vehaskari , VM. 2007:490) and subsequent increased risk for the development of 
chronic kidney disease (CKD), is a case in point, since it is more common in impoverished 
population groups living in Africa. However, most publications describing the influence of 
LBW on CKD come from developed countries. (Teeninga et al. 2008:1615)  
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Limited resources are often the stumbling block for clinicians in developing countries. For 
the standard care of a child with INS the minimum investigations necessary in the work-up 
include urine biochemistry, urine microscopy and investigations to exclude infectious and 
immune disorders. A kidney biopsy is recommended for all children and should include 
light microscopy, immuno-histochemistry or immunofluorescent studies and electron 
microscopy. These investigations are costly, but essential to make a definitive diagnosis. 
Without a specific diagnosis of the underlying pathology and the associated complications it 
will not be possible to make reliable recommendations for targeted treatment in a child with 
INS in a developing country. 
2. Aim 
The aim of the study is to describe the clinical characteristics, histological subtypes, response 
to treatment and outcome of children with INS treated at the paediatric renal unit of the 
Steve Biko Academic Hospital (SBAH). This is a level 3 South African hospital, affiliated to 
the University of Pretoria and the referral centre for the surrounding multiracial population 
of roughly 5 million children under the age of 14 years. 
3. Methods 
A retrospective audit was performed of consecutive children admitted with a clinical diagnosis 
of INS. The latter was defined as ≥2+ proteinuria on a urine dipstick test, hypoalbuminaemia 
of <25 g/L and oedema. Children who had macroscopic haematuria (red or brownish 
discolouration of urine) substantiated by >2+ blood on a urine dipstick test and hypertension 
in addition to the criteria for INS, were also included and were categorised as nephritic-
nephrotic. Hypertension was diagnosed according to the 4th Report of the National High Blood 
Pressure Education Program Working Group on High Blood Pressure in Children and 
Adolescents. (The Fourth Report of the National High Blood Pressure Education Program 
Working Group on High Blood Pressure in Children and Adolescents. 2004:555).  
The racial groups were documented as black, white, Indian, and mixed. The Indian and 
white racial groups were pooled and categorised as white. The black and mixed racial 
groups were similarly pooled and categorised as black. This grouping was done because of 
known similarities in clinical presentation, response to treatment and outcome in the 
respective groups. (Bhimma et al.1997:429). 
The clinical characteristics analysed were age at presentation, gender, anthropometry 
(height/length for age and weight for age), and blood pressure.  
The following investigations were analysed: urine dipstick tests, urine protein:creatinine 
ratio (mg/mg), s-albumin and s-cholesterol, s-creatinine and estimated glomerular filtration 
rate (eGFR) in ml/min/1.73m2. eGFR was calculated using a modified Schwartz formula 
(Schwartz. et al. 1987:571), i.e.: [40 x height (cm)/s-creatinine (µmol/L)]. Kidney function at 
presentation was categorised according to the National Kidney Foundation Kidney Disease 
Outcomes (K/DOQI clinical practice guidelines 2002:S1). Investigations to rule out 
secondary nephrotic syndrome include: the third and fourth components of complement 
(C3 and C4), immunologic tests for systemic lupus erythematosus (antinuclear antibodies 
and anti-double-stranded DNA antibodies), antistreptolysin O and anti DNase B titers, 
hepatitis B and C serology, cytomegalovirus (CMV) antibodies and HIV enzyme-linked 
immunosorbent assay (ELISA). 
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The indications for a kidney biopsy were: a family history of kidney disease, congenital and 
infantile nephrotic syndrome, children with clinical features suggestive of nephrotic 
syndrome (NS) other than MCNS, children who failed to respond to an 8-week course of 
corticosteroids, prior to the administration of cyclophosphamide, children with persisting 
elevated s-creatinine levels and all black children.  
4. Treatment  
The mainstay of treatment was corticosteroids with the aim to achieve and maintain 
remission rather than adhering to a standardised protocol. For this reason a higher dose and 
a longer course were used (daily dose versus alternate day treatment) compared to the 
ISKDC guidelines (International Study of Kidney Disease in Children 1978:159). The 
primary contraindications for corticosteroid treatment were children with CNS, secondary 
NS (e.g. hepatitis B associated nephropathy, Henoch-Schőnlein purpura), children with 
CKD Stage 3 or more associated with stunting and wasting, cardiomegaly, anaemia and 
bone mineral disease and presumably immune-compromised children.  
Second line immunosuppressive therapy was initiated in a selective group of children, 
influenced by compliance and socio-economic factors, and only after parental consent had 
been obtained. Indications for second line immunosuppressive therapy included children 
with steroid dependent or frequently relapsing NS, those who developed secondary steroid 
resistance and a selective group of children with partial response. Exclusion criteria for 
cyclophosphamide treatment included children with underlying chronic infections, e.g. 
untreated Mycobacterium tuberculosis or HIV infection and those at increased risk of 
developing acute or chronic infections due to poor nutritional status.  
4.1.1 Corticosteroid treatment 
Prednisone was administered as a single daily dose at 2 mg/kg/day and tapered to 1 
mg/kg/day after 4 weeks in children who responded and achieved remission. Further 
tapering was only initiated after another 4 weeks and treatment stopped after a total of 20 
weeks. For those who had not responded to corticosteroid treatment at a dose of 2 
mg/kg/day by the 4th week – which occurred commonly in the event of black children - 
this high dose was continued for a maximum of 8 weeks when the dose was tapered 
according to the response of the child.  
Response to treatment was classified as: remission, partial response and steroid resistant. 
Remission was defined as no or trace proteinuria on dipstick test for three consecutive days 
or urine protein:creatinine ratio of <0.2 mg/mg. Relapse was defined as proteinuria of ≥ 2+ 
on dipstick test for three consecutive days or urine protein:creatinine ratio of ≥ 2.0 mg/mg. 
Partial response was defined as  2+ proteinuria on urine dipstick or urine 
protein:creatinine ratio < 2.0 mg/mg after a maximum of 8 weeks of high dose steroid 
treatment (2 mg/kg/day). Steroid resistance was defined as persistent proteinuria ≥2+ and 
urine protein:creatinine ratio ≥ 2.0 mg/mg after a maximum of 8 weeks of high dose steroid 
treatment (2 mg/kg/day). Steroid dependence was defined as relapse when the dose of 
corticosteroid treatment was decreased or within two weeks after stopping it. Frequent 
relapse was defined as ≥2 relapses per 12-month period. 
4.1.2 Cyclophosphamide treatment  
The total course of oral cyclophosphamide for an individual child was calculated as  
168 mg/kg over 8 or 12 weeks administered as 3 mg/kg/day for 8 weeks or 2 mg/kg/day 
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for 12 weeks (=168 mg/kg). Cyclophosphamide tablets are sugar coated and contain 50 mg 
cyclophosphamide/tablet. It cannot be crushed or divided. The dose to be taken per 7-day 
week was therefore calculated for each patient and was limited to a maximum dose of  
3 mg/kg/day. Tablets were administered for fewer than seven days per week for smaller 
patients weighing less than 25 kg who required <50 mg/day (i.e. no treatment on weekend 
days).  
A kidney biopsy was performed in all children before cyclophosphamide treatment was 
initiated. No child received a second course of cyclophosphamide.  
4.1.3 Intravenous methylprednisolone pulse treatment 
A course of intravenous methylprednisolone was administered in three scenarios, i.e. 
children with anasarca and who were resistant to their first course of oral corticosteroid 
treatment, children who became steroid dependent or developed frequent relapses after 
having had a course of cyclophosphamide treatment and children with partial response to 
oral corticosteroid and cyclophosphamide treatment. Selection of patients for this form of 
treatment was further influenced by their ability or willingness to frequently return to the 
hospital and by the absence of recurrent infections.  
Intravenous corticosteroid treatment consisted of methylprednisolone 30 mg/kg/dose 
(maximum dose of 1000 mg) administered according to established guidelines (Mendoza et 
al 1990:303), but excluding cyclophosphamide treatment (Table 1).  
It was discontinued when a patient experienced unacceptable adverse effects, e.g. 
progressive fluid retention or volume overload, with worsening hypertension or when 
proteinuria remained unchanged after 6 to 8 weeks.  
 
Week M-Pa N Prednisone 
1-2 
3-10 
11-18 
19-52 
53-78 
30 mg/kg thrice weekly 
30 mg/kg per week 
30 mg/kg per 2 weeks 
30 mg/kg per 4 weeks 
30 mg/kg per 8 weeks 
6 
8 
4 
8 
4 
None 
2 mg/kg/day b 
1.5mg/kg/day tapered slowly 
1 mg/kg/day tapered slowly 
0.5mg/kg/day tapered slowly 
a = Maximum dose 1000 mg 
b = Maximum dose 60 mg 
Table 1. Intravenous methylprednisolone (M-P) pulse regimen 
4.1.4 Adjunctive treatment  
Adjunctive treatment included diuretics for symptomatic management of oedema, 
antihypertensive drugs, multivitamin and folic acid supplementation, alpha-calcidol for 
children on high-dose corticosteroid treatment and with persisting nephrotic-range 
proteinuria. Treatment with an angiotensin converting enzyme inhibitor (ACE-inhibitor) 
was given for its antiproteinuric effect to alleviate persistent proteinuria and as an 
antihypertensive drug if needed. Other antihypertensive drugs used included a ǃ-blocker 
(atenolol), calcium antagonist (amlodipine), ǂ-blocker (prazosin) and a vasodilator 
(hydralazine). Angiotensin receptor blockers were not prescribed because of 
unavailability. 
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Diuretics of all classes, namely furosemide, hydrochlorothiazide and spironolactone were 
used in combinations if needed for children with diuretic-resistant NS. Hydroxy-
methylglutharyl coenzyme A reductase inhibitors (statins) were selectively prescribed to 
children older than 5 years with persistent NS associated with an elevated total cholesterol 
level of >10 mmol/L. All children received a diet containing reduced salt and saturated fat. 
Protein intake was not restricted.  
5. Ethical approval 
The study was approved by the University of Pretoria Research Ethics Committee and 
permission was obtained from the chief executive officer of the hospital to access hospital files.  
6. Statistical analysis 
Categorical data was reported as proportions and quantitative data as means (standard 
deviations) and medians (range).  
Frequencies of variables within groups were compared using the two-sided Fisher exact test 
and a p-value <0.05 was regarded as significant. Renal and patient survival in the two 
population groups were assessed using Kaplan Meier non parametric life table survival 
analysis.  
7. Results  
Over a period of 23 years (1986 – 2009) 358 children with a clinical diagnosis of NS were 
admitted and comprised the study group. Of these 278/358 (77.7%) were black and 80/358 
(22.3%) white. The median age was 58 months (range 0.5 – 144 months) and the male: female 
ratio 1.3:1.  
The age at presentation was categorised in 4 groups as depicted in table 2. Twenty seven 
children were  12 months of age at the time of presentation, of whom 15/27 (4%) presented 
within the first 3 months of life and were diagnosed with CNS. An additional ten children 
were also diagnosed with CNS but were referred later, when they were older than 3 months. 
Fifty percent (179/358) of the children were in the age group >12-72 months.  
 
Age category (months) Number % 
   
0-3 15 4.2 
>3-12 12 3.3 
>12 - 72 179 50.0 
>72 152 42.5 
Total 358 100% 
Table 2. Age Categories of Children at Presentation  
Stunting (height/length for age z-score > -2SD) was present in 88/358 (24.6%) children. 
Microscopic haematuria was present in 52/109 (47.7%) and macroscopic haematuria in 
34/109(9.5%) children with MCNS.  
A constellation of clinical and laboratory features including, age >12 months to 72 months, 
normal blood pressure, absence of haematuria, normal renal function and normal levels of 
www.intechopen.com
 
An Update on Glomerulopathies – Clinical and Treatment Aspects 
 
444 
serum C3 have been quoted as suggestive of MCNS with an expected good prognosis 
(International Study of Kidney Disease in Children 1978:159). In this study 67% of the 
children with MCNS fulfilled the criteria for the diagnosis, apart from not having a normal 
blood pressure. This finding has been described by others (Habib et al 1971) which 
questions the validity of the criteria for diagnosing MCNS.  
Hypertension was present in 227/358 (63.4%) children at presentation of whom 171/227 
(47.8%) required treatment with antihypertensive drugs for at least 6 weeks. Diuretics were 
used for symptomatic management of oedema and were often used as a first line 
antihypertensive drug in children considered to have volume overload. Of those with 
persistent hypertension 146/171 (85.4%) received an ACE-inhibitor as the preferred 
antihypertensive drug. Overall 213/358 (59.5%) received an ACE-inhibitor for its anti-
proteinuric effect. Renal function and s-potassium were monitored in all children who were 
treated with an ACE-inhibitor. No child experienced an allergic response or developed 
significant coughing with this treatment. An acute increase in s-creatinine levels occurred in 
some patients, usually in association with volume contraction, which was reversible in all 
cases with fluid resuscitation.  
The mean s-albumin level at the time of presentation was 13.2  5.2 g/L. Some patients had 
below detectable s-albumin levels and for these the lowest value documented was an 
arbitrary level of 10g/L for the purpose of statistical analysis. This means that the true mean 
level was in fact lower. The mean s-cholesterol at the time of presentation was 11.4  7.3 
mmol/L. As already stated above, statins were only prescribed to a limited number of older 
children with persistent hypercholesterolaemia. The main reason why younger children 
with similar high cholesterol levels were not treated with statins is the lack of long-term 
safety information on the effects of these drugs on the developing brain, immune functions, 
hormones and energy metabolism.  
Kidney function was monitored using change in eGFR over time. Despite its limited 
accuracy, especially in children with poor muscle bulk, it was the only feasible test which 
could be done at regular intervals at follow-up visits. The results of eGFR at the time of 
presentation and at last follow up for the two race groups are depicted in table 3. 
 
CKD 
Stage 
eGFR1 
(ml/min/1.73m2)
eGFR at presentation 
n = 358 
eGFR last follow up 
n = 358 
   
Black children
n=278 
White children
n=80 
Black children
n=278 
White children 
n=80 
1 ≥90 189 (68.0%) 55 (68.8%) 178 (64.0%) 66 (82.5%) 
2 60-89 42 (15.1%) 20 (25.0%) 29 (10.4%) 10 (12.5) 
3 30-59 27 (9.7%) 4 (5.0%) 18(6.5%) 1 (1.3%) 
4 + 5 <29 20 (7.1%) 1(1.3%) 53(19.0%)* 3 (3.8%) 
eGFR = Estimated glomerular filtration rate  
*One black child with CKD stage 5 who had a successful kidney transplant is included in the number of 
black children with stage 4 and 5 CKD. 
Table 3. eGFR at the Time of Presentation and During Follow Up in the Two Race Groups 
Significantly more black compared to white children had stage 4 or 5 CKD on presentation, 
7.1% vs. 1.3% respectively (p=0.03), or had developed stage 4 or 5 CKD at the time of last 
follow up, 19.0% vs. 3.8% respectively (p= 0.000). 
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A secondary cause for NS was identified in 26 (7.2%) children including Henoch-
Schőnlein purpura, systemic lupus erythematosus, chronic hepatitis B infection, HIV 
infection and IgA glomerulonephritis. Ten children (2.8%) had chronic hepatitis B 
associated nephropathy. None of them were given any immunosuppressive treatment, 
interferon or other specific antiviral treatment. In eleven children a genetic cause of NS 
was suspected.  
CNS was diagnosed in 25/358 (7%) children, none of whom had a syndromic form of CNS. 
Investigations for mutations of NPHS1, NPHS2 and WT1 were not done in any of the 
children with CNS or suspected familial NS because of unavailability.  
Kidney biopsies were performed in 318/358 (89%) children. The main histological diagnoses 
are depicted in table IV. Eighteen children had inconclusive histology which was reported 
as “FSGS cannot be excluded.” In these cases there was a chronic inflammatory cell infiltrate 
in the interstitium, interstitial fibrosis and tubulo-interstitial atrophy suggestive of FSGS but 
the biopsy sample did not have glomeruli with focal sclerosis. If this group of children is 
added to the group with definite FSGS, the frequency of FSGS increases to 98/318 (31%). 
Eleven children (10 black, 1 white) were diagnosed with immune complex 
glomerulonephritis (ICGN), based on the presence of immune deposits in the basement 
membrane on electron microscopy examination and another 26 (25 black, 1 white) had 
ICGN with secondary glomerular sclerosis. 
 
Histological diagnosis 
White  
Number (%)
Black  
Number (%)
Total  
 (%) 
 p-value 
     
MCNS  42(66) 67(26.4) 109 (34.2) <0.001* 
Focal segmental glomerulosclerosis (FSGS) 9 (14)  71(28) 80 (25) 0.01* 
MCNS – FSGS ** 7(11) 11 (4.3)  18 (5.7) 0.048* 
Immune complex glomerulonephritis (ICGN) 1(1.6) 10 (4) 11(3.4) 0.31 
ICGN and secondary FSGS 1 (1.6)  25( 9.8)   26 (8.2) 0.02* 
Membranous nephropathy (MN)  0 (0) 14 (5.5) 14 (4.4) 0.04* 
Mesangiocapillary glomerulonephritis 1 (1.6) 12 (5)   13 (4) 0.22 
Congenital nephrotic syndrome (CNS)  0 (0) 25 (9.8) 25 (8) 0.02* 
Other  3 (4.7) 19 (7.5) 22 (7)  
     
Total *** 64(100) 254 (100) 318 (100)  
*Statistically significant 
**MCNS-FSGS: Histology was reported as “FSGS cannot be excluded” and was therefore inconclusive 
but very suggestive of FSGS due to the presence of a chronic inflammatory cell infiltrate in the 
interstitium, interstitial fibrosis and tubular atrophy on the biopsy.  
***Includes all children who had kidney biopsies, including the children with congenital nephrotic 
syndrome. 
Table 4. Main Histological Subtypes of Nephrotic Syndrome (n = 318) 
In table 5. the frequencies of all the histological subtypes excluding CNS are depicted, which 
is in line with the procedure followed by the ISKDC. CNS is considered a distinct form of 
NS with a unique etio-pathogenesis and a high frequency of underlying genetic mutations 
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and is therefore usually not analysed with other forms of INS. Kidney biopsies were done in 
318 children (64 white and 254 black). After exclusion of the 25 children with CNS, all of 
whom were black, the frequencies of the histopathological subtypes of only the remaining 
229 black children changed.  
 
Histological diagnosis 
White  
Number (%)
Black  
Number (%) 
Total  
 (%) 
 p-value 
     
MCNS 42(65.6) 67(29.3) 109 (37.2) <0.000* 
Focal segmental glomerulosclerosis (FSGS) 9 (14.0)  71(31.0) 80 (27.3) 0.004* 
MCNS – FSGS ** 7(10.9) 11 (4.8)  18 (6.1) 0.07 
Immune complex glomerulonephritis (ICGN) 1(1.6) 10 (4.4) 11(3.7) 0.26 
ICGN and secondary FSGS 1 (1.6)  25( 11.0)   26 (8.9) 0.01* 
Membranous nephropathy 0 (0) 14 (6.1) 14 (4.8) 0.03* 
Mesangiocapillary glomerulonephritis 1 (1.6) 12 (5.2)   13 (4.4) 0.18 
Other  3 (4.7) 19 (8.3) 22 (7.5)  
     
***Total  64 (100) 229 (100) 293 (100)  
*Statistically significant  
**MCNS-FSGS: Histology was reported as “FSGS cannot be excluded” and was therefore inconclusive 
but very suggestive of FSGS due to the presence of chronic inflammatory cell infiltrate in the 
interstitium, interstitial fibrosis and tubular atrophy on the biopsy.  
***All children who had kidney biopsies, but excluding the children with congenital nephrotic 
syndrome. 
Table 5. Histological Subtypes of Nephrotic Syndrome Excluding Children with Congenital 
Nephrotic Syndrome (n=293) 
The incidences of the four major histological subtypes (MCNS, FSGS, membranous 
nephropathy, mesangiocapillary glomerulonephritis were significantly higher in the black 
children (Table 5). 
7.1 Results of treatment  
Remission with oral corticosteroid treatment was achieved in 33/41(81%) white vs 
33/59(56%) black children (p=0.02) who had MCNS. The response rate of the black children 
is similar to the 60% response rate in black children reported previously from Kalafong 
Hospital (Prinsloo JG. 1986:375) but lower than the 78% response rate reported a decade 
later in children from the Chris-Hani Baragwanath Hospital (Johannesburg), both tertiary 
hospitals in South Africa (Thomson 1997:402). Oral corticosteroid treatment resulted in 
remission in 3/9 white children and 8/40 black children with FSGS (p=0.6). In the combined 
group of children with FSGS and MCNS-FSGS 9/13 (69.2%) white children vs 4/14 (28.5%) 
(p<0.05) black children went into remission with this treatment. Twenty five children who 
failed to respond to oral corticosteroid treatment were treated with a course of intravenous 
methylprednisolone of whom only 4 (one white and 3 black children) went into complete 
remission. This form of treatment was abandoned because of its poor efficacy, high toxicity 
and cost and the disruptive effect it had on school attendance. Hundred children were 
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treated with cyclophosphamide, 46 were white and 54 black. The response rate to this 
treatment was statistically significantly different in the white and black children. Sustained 
remission was achieved in 37/46 (80%) white and in 23/54 (43%) black children (P=0.002; 
95% CI 2.2 – 13.7). The ISKDC reported no benefit of orally administered cyclophosphamide 
and prednisone compared to prednisone alone for the treatment of steroid resistant NS 
(Tarshish, P et al. 1996: 590). Their report and the poor response of children with steroid 
resistant NS in this study prompted discontinuation of cyclophosphamide treatment in 
children with steroid resistant NS since 2007. No patient experienced side effects of 
cyclophosphamide treatment, but they were all monitored at least every 10 to 14 days 
throughout the duration of the treatment. Several children who had been in contact with 
chicken pox were given human varicella-zoster immune globulin and/or acyclovir 
prophylactically, but none developed serious chicken pox.  
7.2 Morbidity and mortality 
Acute reversible renal failure occurred in 35/358 (9.8%) children and thrombotic 
complications, other than strokes in 9/358 (2.5%). Six children (1.7%) developed strokes, one 
of whom developed bilateral sequential middle cerebral artery thromboses a few months 
apart. She was one of a family of 3 children who all had steroid resistant NS. At the time that 
she developed the first stroke she was not dehydrated, but had a mild lower respiratory 
tract infection, iron deficiency anaemia and a thrombocytosis, which are known risk factors 
for thrombo-embolic complications in children with nephrotic syndrome.  
Fourty eight percent of all children experienced acute invasive bacterial infections, including 
pneumonia, peritonitis and septicaemia. In those with steroid sensitive NS acute bacterial 
infections occurred during relapses. The frequency of infection was inversely related to age 
and was particularly high in children younger than 3 months. Of these children 87% 
developed serious infections compared to 39% of children older than 6 years. Streptococcus 
pneumoniae was the predominant causal organism, followed by Escherichia coli and other 
gram negative organisms. Twenty six children (7.3%) developed peritonitis of whom three 
demised due to pneumococcal septicaemic shock. Pneumococcal infections occurred in 7/80 
(8.7%) white children vs 19/278 (6.8%) black children (p=0.6). Until recently pneumococcal 
polysaccharide vaccine was given to all children younger than 5 years at the time of their 
first presentation, despite its limited efficacy in children younger than 2 years. Since 2009 the 
pneumococcal conjugate vaccine is available in South Africa which is used for revaccination 
of this group of children. Long term prophylactic penicillin was not used.  
Chronic hepatitis B infection (positive HBsAg and/or HBeAg) occurred in 10/358 (2.8%) 
children, all of whom were black. Hepatitis B vaccine was included in the routine 
immunization schedule of children in South Africa since 1991 and since that time no child 
was diagnosed with hepatitis B related NS. No child had hepatitis C related NS. 
Investigations to rule out CMV infection were only done in children with CNS and in those 
with atypical clinical features of NS, including anaemia, hepatosplenomegaly, skin rash or 
positive central nervous system signs. In most cases only CMV IgM and IgG were done, 
which were often both positive due to unexplained reasons at the time, because the test for 
CMV viral load was not available. Should a CMV infection be diagnosed it is not necessarily 
proof of the causality of the NS.  
All children were screened for underlying Mycobacerium tuberculosis infection with a chest 
X-ray, gastric aspirates or induced sputum cultures and Mantoux test (skin prick test with 
intradermal injection of purified protein derivative of Mycobacterium tuberculosis). Because 
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children uncommonly have sputum positive tuberculosis, several of our patients received 
empiric anti-tuberculous treatment for 6 months when the diagnosis could not be 
unequivocally excluded. A high prevalence of tuberculosis associated with a deleterious 
effect on renal function was reported in black children with FSGS. (Kala et al.1993:392). It 
has been postulated that immune responses mediated by infections with Mycobacterium 
tuberculosis and HI-virus may contribute to glomerulosclerosis. Mycobacterium 
tuberculosis infection was present in too few patients in this study to draw any conclusion.  
Investigations for HIV infection were only done in children who had clinical features 
suggestive of the disease and whose parents had given consent to testing. It is therefore not 
possible to report on the true incidence of NS associated with HIV infection. Patients with HIV 
infection had a variety of histological lesions, including, immune complex glomerulonephritis, 
immunotactoid and fibrillary glomerulonephritis and FSGS. No patient had HIV collapsing 
glomerulopathy which has been reported as one of the commonest histological lesions in black 
adult patients with HIV infection. Recently HIV- associated kidney disease has been reported 
to have become the most common form of kidney disease in children seen in the renal unit at 
one of the academic hospitals in South Africa. (Bhimma R, 2009:15) 
Only one infant with CNS had congenital syphilis and treatment with penicillin did not 
result in cure of the disease. Chronic “quartan malarial nephropathy” or other parasitic 
related forms of NS did not occur.  
7.3 Outcome 
At presentation 21/358 children had CKD stage 4 or 5. Of the black children 20/278 (7.2%) 
had CKD stage 4 or 5 compared to 1/80(1.3%) white children (p=0.03). Over the period of 
follow up more black children (53/278) (19%) developed stage 4 or 5 CKD compared to 
white children (3/80)(3.8%)(p= 0.000). Kaplan-Meier estimation of renal survival depicting 
the difference in renal survival in black and white children  is demonstrated in Fig1. One 
black child was successfully transplanted during the follow up period and had normal renal 
function at last follow up. Persistent nephrotic range proteinuria is associated with a rapid 
progression to end-stage kidney disease. Several children in this study had long standing 
suboptimal management of nephrotic range proteinuria when presenting to the SBAH 
which contributed to a more rapid progression to end stage kidney disease. 
Forty three patients died during the follow up period. Three (3.7%) white children died of 
whom 2 succumbed to complications of renal failure (renal deaths) and one died due to 
pneumococcal septicaemia (non renal death). Forty black children died during the follow up 
period, mostly due to end stage renal failure. In the black children infectious related deaths 
occurred mostly in the children with congenital NS. Black children had a significantly 
higher mortality compared to white children (40/268 vs. 3/80) (p<0.001). Kaplan-Meier 
patient survival estimate depicting the difference in patient survival for black and white 
children  is demonstrated in Fig 2. 
8. Discussion  
This study population differs in several aspects from those reported from developed 
countries. The majority of patients are black with an inherent risk of CKD due to a genetic 
predisposition aggravated by poor socio-economic circumstances and chronic infections. 
Poor prognostic indicators namely stunting, profound hypoalbuminaemia, long standing 
nephrotic-range proteinuria, hypertension and impaired kidney function are common at 
presentation against a background of tuberculosis and HIV infection. 
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Fig. 1. Kaplan-Meier estimation of renal survival  
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Fig. 2. Kaplan-Meier estimation of patient survival  
www.intechopen.com
 
An Update on Glomerulopathies – Clinical and Treatment Aspects 
 
450 
The results of this audit confirm that significant racial differences exist in the clinical 
presentation, histological subtypes, response to treatment and outcome in South African 
children with NS. Similar findings have been reported by other study groups in South 
Africa (Bhimma et al. 2006: 1847; Bhimma R, 1997: 429), from other countries in Africa (Yao 
Doe, J. et al. 2006: 672; Olowu et al. 2010:200) and also from elsewhere in the world (Ingulli, 
E. & Tejani, A. 2001:393). In their study on idiopathic FSGS in children Ingulli et al. (Ingulli, 
E. & Tejani, A. 2001:393) reported that the rate of FSGS was higher (32.2% vs. 20%), and 
progress to end stage kidney disease was more common (78% vs. 33%) in black and 
Hispanic compared to white children. Olowu et al. (Olowu et al. 2010:200) reported an 
incidence of 18.5 % MCNS and 25.9% FSGS in their study of black Nigerian children with 
INS. Ethnic differences in the incidences of FSGS have now been well established. Over the 
past 10 years there have been several reports of an increasing incidence of FSGS in children 
(Borges et al. 2007:1309; Filler et al. 2003: 1107)   
In this study 77% of the children were black and 23% were white. There was a significant 
difference in the incidences of the main histological subtypes (MCNS, FSGS, immune 
complex glomerulonephritis, secondary FSGS and membranous nephropathy) between 
black and white children. The incidence of MCNS was 65.6% and 29.3% (p<0.000) and of 
FSGS, 14% and 31% (p=0.004) in white and black children respectively.  
The first course of corticosteroid treatment was often longer or more intense than that 
recommended by the ISKDC (International Study of Kidney Disease in Children: 1978:13) 
because of delayed achievement of remission or only partial response after the first four 
weeks. Corticosteroid treatment was also often given daily rather than on alternate days 
because parents failed to understand alternate day dosing schemes. White children with 
MCNS had a better response to oral corticosteroid treatment compared to black children 
with MCNS (80% vs 56%; p=0.02). Remission with oral corticosteroid treatment was 
achieved in more white children with FSGS compared to black children with FSGS, 
although this difference did not reach statistical significance (33% vs 20 %; p=0.6). Response 
rates in both race groups in this study were much lower compared to the 93.1% response 
rate reported by the ISKDC (International Study of Kidney Disease in Children: 1978:13). 
After 2000 we stopped using high dose intravenous methylprednisolone for the treatment of 
steroid resistant NS in our patients for several reasons. It is too costly, it places a heavy 
burden on the family and child, and only 4 of 25 children (16%) went into remission with 
this treatment. This very poor response rate compared to that of Mendoza et al (Mendoza, 
S.A. et al. 1990:303), who reported complete remission in 52% of their patients, can possibly 
be explained by the fact that we omitted an alkylating agent in our treatment regimen. 
Adhikari et al (Adhikari et al. 1997:423) reported a dismal outcome in 12 South African 
children with FSGS who were treated with a combination of intravenous 
methylprednisolone and an alkylating agent. Although they considered this treatment as 
“promising,” their patients developed serious side effects including alopecia, cataracts, 
leukopaenia, systemic candidiasis, gram negative septicaemia, and one child demised of a 
serious infection which was undoubtedly caused by the severe immune suppression 
associated with the treatment. 
Infections remain a serious risk to all children during a relapse of NS, which is practically 
always for those with steroid resistant NS. This risk is intensified in those living in poor 
socio-economic circumstances. Forty eight percent of our patients experienced acute 
invasive bacterial infections and three succumbed to documented pneumococcal 
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septicaemia. Management of the children with CNS was particularly challenging, due to 
their serious immune compromised state and high frequency of recurring infections. All 
children with CNS were black and screening for a possible infectious cause was not very 
fruitful. Genetic studies were not undertaken in any of our patients as we do not have access 
to genetic laboratory services. Kidney biopsy revealed idiopathic FSGS or secondary 
glomerular sclerosis in 15/25 children with CNS. A very dense chronic inflammatory cell 
infiltrate was present in all cases. Children with CNS were not treated with corticosteroids 
or other immunosuppressive drugs. Most of them remained in hospital for long periods or 
required frequent admissions for treatment of bacterial infections or gastroenteritis. An ACE 
inhibitor was not prescribed to any child less than 3 months old and was usually only given 
to children older than 12 months.  
Because of the lower incidence of MCNS in black children in South Africa first reported in 
1979, (Bhimma et al. 1997:429; Lewin, et al. 1979: 88) it has been our practice to biopsy all 
black children at the time of their first presentation. For the same reason paediatric 
nephrologists elsewhere in Africa have also advocated pre-treatment renal biopsies in their 
patients. Olowu et al. (Olowu et al. 2010:200] reported that only 18.5% of the black children 
with INS in their study of Nigerian patients had MCNS.  
Most centres in developed countries are still following the ISKDC recommendation 
regarding biopsies despite worldwide reports of an increasing incidence of FSGS in both 
children and adults. Filler et al (Filler et al. 2003 :1107) reported a declining incidence of 
MCNS from 81.1% to 64% and an increasing incidence of FSGS from 10.8 to 24.7% of FSGS 
in their childhood population in Ontario, over two time periods 1985-1993 and 1993-2002. 
The incidence of MCNS in the first period did not differ significantly from that reported 
by the ISKDC (International Study of Kidney Disease in Children 1978: 13) and although 
not specifically reported, the inference is made that the majority of their patients 
responded to corticosteroid therapy. The incidence of FSGS in their patients has more 
than doubled over 17 years while the population under study remained stable. Race is not 
mentioned in their study. Despite an alarming increase in the incidence of FSGS in their 
patients, they argue that empirical steroid treatment with a cut-off point at 28 days is  
still justifiable. During the second period of their study the incidence of MCNS is similar 
to the incidence of MCNS in white children in our study, 64.7% vs. 65.6 % and the 
incidence of FSGS slightly less than that of FSGS in black patients in our study 24.7%  
vs. 31%.  
Already in 1997 Thomson et al. (Thomson, P.D. 1997:508), performing pre-treatment 
biopsies in all their black patients, reported an incidence of FSGS in 31.3% which is identical 
to the 31% incidence of FSGS in black patients in this study. It appears that there has not 
been an increase in the incidence of FSGS in black children in Gauteng Province in South 
Africa over this period.  
It can be expected that the HIV epidemic has contributed to the incidence of CKD in South 
Africa in general, but its possible role in the development of FSGS, or its contribution to an 
increase in the incidence of FSGS, is uncertain. Local multi-centre prospective research 
studies in patients with HIV-associated nephropathy will be necessary to explore this 
question.  
Primary FSGS is a spectrum of podocytopathies caused by a variety of contributing 
etiologies, including genetics, infections, environment, including the intra-uterine 
environment, drugs and toxins. It is an aggressive disease, more so in black children 
compared to white children. The rationale of performing a kidney biopsy at presentation is 
www.intechopen.com
 
An Update on Glomerulopathies – Clinical and Treatment Aspects 
 
452 
that it confirms the histological subtype and may give clues to the stage and type of initial 
injury. It has been suggested that the different variants of FSG may respond differently to 
treatment (Valeri. et al. 1996: 1734). Immuno-histochemistry and electron microscopy may 
also help in differentiating primary and secondary forms of FSGS. It is well known that 
patients with extensive involvement of glomeruli, advanced tubulo-interstitial fibrosis and 
tubular atrophy are less likely to respond to corticosteroid treatment compared to those with 
no interstitial involvement. It is questionable whether it is justifiable to expose such a patient 
who may also happen to be malnourished and have poor social circumstances to aggressive 
immune suppression for a disease which may not have an immunological background. The 
possible departure of many of our black patients from a hostile intra uterine environment 
resulting in low birth weight and low glomerular endowment is an aspect which has not 
been investigated systematically.  
9. Conclusions 
Compared to the ISKDC report black children have a lower incidence of MCNS and a higher 
incidence of FSGS. Black children also have a more aggressive form of FSGS which responds 
poorly to corticosteroid and other immuno-suppressive treatment. More black children 
develop CKD stage 4 and 5 compared to white children and black children have a higher 
mortality compared to white children. The results of this study and similar evidence from 
the rest of Africa suggest that the ISKDC recommendation of empiric corticosteroid 
treatment in children with INS should not be followed in the management of black children 
with INS. We suggest that a kidney biopsy should be done at presentation to allow a 
definitive diagnosis and targeted treatment from the outset.  
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